SCHEMBL5186

SCHEMBL5186

C[C]1CCC1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9766018 0.78
SCHEMBL10582110 0.78 NOS3 (0.34)
SCHEMBL5278 0.76
SCHEMBL4468 0.74
SCHEMBL258383 0.72
SCHEMBL21114252 0.72 KMT2A (0.54)
SCHEMBL21114295 0.72 KMT2A (0.54)
SCHEMBL21114291 0.72 KMT2A (0.54)
SCHEMBL10866902 0.72 KMT2A (0.54)
SCHEMBL1532392 0.72 KMT2A (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2038 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024126648-A1 SULFOXIMINES AS INHIBITORS OF NaV1.8 Grünenthal GmbH (DE) 2024-06-20 WO claimed
EP-4385984-A1 PYRIDINE-N-OXIDES AS INHIBITORS OF NAV1.8 Grünenthal GmbH (DE) 2024-06-19 EP claimed
EP-4385980-A1 INDAZOLES AS INHIBITORS OF NAV1.8 Grünenthal GmbH (DE) 2024-06-19 EP claimed
EP-4385979-A1 MULTICYCLIC INHIBITORS OF NAV1.8 Grünenthal GmbH (DE) 2024-06-19 EP claimed
CN-113423745-B Method for producing polymer having compatibility with biological material 日产化学株式会社 2024-01-09 CN claimed
WO-2023092195-A1 ANALOGUES OF MDMA FOR MODULATING SERT, DAT, AND / OR NET ACTIVITY THE UNIVERSITY OF WESTERN AUSTRALIA (AU) 2023-06-01 WO claimed
US-11612606-B2 8-aminoisoquinoline compounds and uses thereof GENENTECH, INC. (US) 2023-03-28 US claimed
EP-3558986-A1 SUBSTITUTED 1,2,4-THIADIAZOLYL PYRROLONES AND 1,2,4-THIADIAZOLYL HYDANTOINES AND SALTS THEREOF AND USE THEREOF AS HERBICIDES Bayer CropScience Aktiengesellschaft (DE) 2019-10-30 EP claimed
CN-110267950-A Substituted heteroaryl pyrrolones and its salt and its purposes as herbicidal active compounds 拜耳作物科学股份公司 2019-09-20 CN claimed
US-10295907-B2 Resist underlayer film-forming composition for lithography containing polymer having acrylamide structure and acrylic acid ester structure NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2019-05-21 US claimed
EP-1086112-A2 1-GALACTOSE DERIVATIVES SYNSORB Biotech Inc. (CA) 2001-03-28 EP claimed
US-6174867-B1 INHIBITION OF THE BINDING OF A TOXIN OR ORGANISM TO ITS CORRESPONDING CELL SURFACE RECEPTOR; E.G., HEAT-LABILE ENTEROTOXIN OR CHOLERA TOXIN OR ENTEROVIRULENT ORGANISMS; BACTERICIDES, VIRICIDES, FUNGICIDES SYNSORB BIOTECH, INC. (CA) 2001-01-16 US claimed
WO-1999058540-A2 1-GALACTOSE DERIVATIVES SYNSORB BIOTECH, INC. (CA) 1999-11-18 WO claimed
EP-0937093-A2 1-GALACTOSE DERIVATIVES SYNSORB Biotech Inc. (CA) 1999-08-25 EP claimed
US-5932554-A PREVENT BINDING OF TOXINS TO RECEPTORS SYNSORB BIOTECH, INC. (CA) 1999-08-03 US claimed
US-5756813-A TREATING RETROVIRUSES SUCH AS HUMAN IMMUNODEFICIENCY VIRUS UNIROYAL CHEMICAL LTD/UNIROYAL CHEMICAL LTEE (CA) 1998-05-26 US claimed
WO-1998021222-A2 1-GALACTOSE DERIVATIVES SYNSORB BIOTECH, INC. (CA) 1998-05-22 WO claimed
EP-0239357-B1 PROCESS FOR PREPARING MONOSODIUM PHOSPHOENOLPYRUVATE AND USE OF THE SAME AS VISCERAL FUNCTION IMPROVER UBE INDUSTRIES, LTD. (JP) 1991-10-16 EP claimed
US-4874882-A HYDROLYSIS OF MONOSODIUM MONOSUBSTITUTED PHOSPHOENOLPYRUVATE UBE INDUSTRIES, LTD. (JP) 1989-10-17 US claimed
EP-0239357-A2 Process for preparing monosodium phosphoenolpyruvate and use of the same as visceral function improver UBE INDUSTRIES, LTD. (JP) 1987-09-30 EP claimed